About us

Héphaïstos is the first French company to develop clinical-grade Artificial Intelligence tools for the pathologist. With Artificial Intelligence, health data and clinical expertise, we will propel cancer care with more powerful and effective tools for diagnosis, treatment selection.

At the heart of Héphaïstos are large-scale machine learning algorithms formed at the megabyte scale from tens of thousands of digital blades. We are developing new in-depth learning algorithms on convoluting neural networks as well as generative models capable of learning effectively from visual and clinical data.